A second-generation “all-inside” meniscal repair system provides a high success rate at long-term follow-up, reports a study in The Journal of Bone & Joint Surgery.
MYK-224 by Bristol-Myers Squibb for Diastolic Heart Failure (HFpEF): Likelihood of Approval
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug